Cancer Therapy–Related Hypertension

Published: January 09, 2023

patient sitting on couch getting vitals taken
  • Anti-cancer drugs have improved cancer survival, but they come with cardiovascular toxicities that can cause incident heart disease, thromboembolic disease and hypertension or they may exacerbate current underlying conditions.
  • One of the most common side effects is hypertension, most notably seen in vascular endothelial growth factor inhibitors, tyrosine kinase inhibitors and proteasome inhibitors.
  • This AHA scientific statement advocates for the team approach to manage these complex patients including oncologists, cardiologists, hypertension specialists, primary care providers and pharmacists.